Evaluation of production cross-sections for 186 Re theranostic radionuclide via charged-particle induced reactions on Tungsten

Ali, Samer K.I.; Khandaker, Mayeen Uddin; Kassim, Hasan Abu

doi:10.1016/j.apradiso.2018.01.035

Cited by 12 publications

(1 citation statement)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All evaluated data are available on the website of the IAEA [9]. Using theory-aided evaluation, some work has been also carried out outside the abovementioned CRPs (see for example [10][11][12][13][14]). The evaluation efforts have provided reliable standardized data for acceleratorbased radionuclides routinely used in patient care (PET/SPECT imaging and internal radiotherapy), produced either directly or obtained through positron-emitting generator systems 68 Ge/ 68 Ga and 82 Sr/ 82 Rb.…”

Section: Availability and Status Of Standardized Datamentioning

confidence: 99%

Continuing Nuclear Data Research for Production of Accelerator-Based Novel Radionuclides for Medical Use: A Mini-Review

et al. 2021

View full text Add to dashboard Cite

Nuclear data are important for production and medical application of a radionuclide. This brief review concentrates on nuclear reaction cross-section data. The availability of standardized nuclear data for accelerator-based production of medical radionuclides is outlined. Some new directions in radionuclide applications, for example, theranostic approach, bimodal imaging, and radionuclide targeted therapy, are considered and the status of relevant nuclear data is discussed. The current trends in nuclear data research using accelerators are elaborated. The increasing significance of intermediate energy accelerators in production of therapeutic radionuclides is emphasized.

show abstract